The current price-to-earnings ratio of ARE can't be determined, as the TTM EPS of -$0.13 is negative. The last recorded PE ratio for Alexandria Real Estate Equities was 121.72 in March 2025.
The average historical PE ratio of Alexandria Real Estate Equities for the last ten years is 74.59. In the past ten years, ARE's PE ratio reached its highest point in the Jun 2017 quarter at 293.83, when the stock price was $120.47 and the EPS was $0.41. The lowest point was recorded in the Jun 2021 quarter, when it reached 27.16 with a price of $181.94 and an EPS of $6.7.
Maximum annual increase: 412.46% in 2023
Maximum annual decrease: -76.92% in 2024
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 54.19 | -76.92% | $97.55 | $1.8 |
2023 | 234.76 | 412.46% | $126.77 | $0.54 |
2022 | 45.81 | -21.3% | $145.67 | $3.18 |
2021 | 58.21 | 96.92% | $222.96 | $3.83 |
2020 | 29.56 | -42.74% | $178.22 | $6.03 |
2019 | 51.62 | 58.1% | $161.58 | $3.13 |
2018 | 32.65 | -60.25% | $115.24 | $3.53 |
2017 | 82.13 | N/A | $130.59 | $1.59 |
2016 | N/A | N/A | $111.13 | -$1.99 |
2015 | 55.44 | -36.9% | $90.36 | $1.63 |
2014 | 87.86 | 120.98% | $88.74 | $1.01 |
2013 | 39.76 | -37.48% | $63.62 | $1.6 |
2012 | 63.6 | 59.52% | $69.32 | $1.09 |
2011 | 39.87 | 19.19% | $68.97 | $1.73 |
2010 | 33.45 | 41.5% | $73.26 | $2.19 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Jun 2025 | N/A | N/A | $72.63 | -$0.13 |
Mar 2025 | 121.72 | 124.62% | $92.51 | $0.76 |
Dec 2024 | 54.19 | -25.16% | $97.55 | $1.8 |
Sep 2024 | 72.41 | -49.86% | $118.75 | $1.64 |
Jun 2024 | 144.41 | 19.86% | $116.97 | $0.81 |
Mar 2024 | 120.48 | -48.68% | $128.91 | $1.07 |
Dec 2023 | 234.76 | 223.63% | $126.77 | $0.54 |
Sep 2023 | 72.54 | 114.74% | $100.1 | $1.38 |
Jun 2023 | 33.78 | 21.55% | $113.49 | $3.36 |
Mar 2023 | 27.79 | -39.34% | $125.59 | $4.52 |
Dec 2022 | 45.81 | 6.53% | $145.67 | $3.18 |
Sep 2022 | 43 | -46.04% | $140.19 | $3.26 |
Jun 2022 | 79.69 | 9.28% | $145.03 | $1.82 |
Mar 2022 | 72.92 | 25.27% | $201.25 | $2.76 |
Dec 2021 | 58.21 | 105.04% | $222.96 | $3.83 |
Stock name | PE ratio | Market cap |
---|---|---|
PFE Pfizer Inc | 17.83 | $140.94B |
BMY Bristol Myers Squibb Co | 18.07 | $98.56B |
GILD Gilead Sciences Inc | 24.36 | $144.54B |
AMGN Amgen Inc | 27.74 | $164.85B |
LLY ELI LILLY & Co | 65.86 | $770.22B |
ALNY Alnylam Pharmaceuticals Inc | N/A | $42.87B |
ILMN Illumina Inc | N/A | $17.3B |
ARE Alexandria Real Estate Equities Inc | N/A | $14.22B |
The current price to earnings ratio of ARE can't be calculated, as its EPS of -$0.13 is negative.
Over the last 3 years, the average PE ratio for ARE stock is 88.26.
Over the last 5 years, the average PE ratio for ARE stock is 70.06.
In the last ten years, the Jun 2017 quarter recorded the highest quarterly PE ratio at 293.83.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.